Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Sims-Mourtada

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Theranostics|June 28, 2012
Long-Term Survival, Toxicity Profile, and role of F-18 FDG PET/CT scan in Patients with Progressive Neuroendocrine Tumors Following Peptide Receptor Radionuclide Therapy with High Activity In-111 PentetreotideEbrahim S Delpassand, Amin Samarghandi, Jennifer Sims Mourtada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
Hedgehog: an attribute to tumor regrowth after chemoradiotherapy and a target to improve radiation responseJennifer Sims-Mourtada, Julie G Izzo, Smith Apisarnthanarax, et al.
Gastrointestinal Cancer Research : GCR|April 11, 2009
Emerging molecular targets in esophageal cancersJulie G Izzo, Rajyalakshmi Luthra, Jennifer Sims-Mourtada, et al.
Genes & Development|November 5, 2025
Mutant p53 binds and controls estrogen receptor activity to drive endocrine resistance in ovarian cancerChunlei Shao, Alexandra Indeglia, Maya Foster, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Theranostics|June 28, 2012
Long-Term Survival, Toxicity Profile, and role of F-18 FDG PET/CT scan in Patients with Progressive Neuroendocrine Tumors Following Peptide Receptor Radionuclide Therapy with High Activity In-111 PentetreotideEbrahim S Delpassand, Amin Samarghandi, Jennifer Sims Mourtada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
Hedgehog: an attribute to tumor regrowth after chemoradiotherapy and a target to improve radiation responseJennifer Sims-Mourtada, Julie G Izzo, Smith Apisarnthanarax, et al.
Gastrointestinal Cancer Research : GCR|April 11, 2009
Emerging molecular targets in esophageal cancersJulie G Izzo, Rajyalakshmi Luthra, Jennifer Sims-Mourtada, et al.
Genes & Development|November 5, 2025
Mutant p53 binds and controls estrogen receptor activity to drive endocrine resistance in ovarian cancerChunlei Shao, Alexandra Indeglia, Maya Foster, et al.
Pageof 4